The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape
Key Highlights
- ➤Rocket Doctor AI completed 53,348 patient visits in Q3 2026.
- ➤U.S. completed visits rose 56% quarter-over-quarter to 6,101.
- ➤Rocket Doctor AI expects record quarterly revenue for Q3 2026.
- ➤Tempus expanded a multi-year collaboration supporting potential intismeran autogene commercialization.
- ➤IQVIA selected Veeva clinical applications as enterprise standards across development studies.
Expert Statements
Dr. Essam Hamza, CEO of Rocket Doctor AI
“Our Q3 performance highlights the accelerating demand for Rocket Doctor AI’s physician-built, AI-powered platform across North America.”
Dr. Essam Hamza, CEO of Rocket Doctor AI
“Surpassing 50,000 total patient visits across Canada and the U.S. in a single quarter is a remarkable operational milestone.”
Dr. Essam Hamza, CEO of Rocket Doctor AI
“The 56% quarter-over-quarter growth in completed U.S. visits demonstrates the successful rollout of our multi-payer strategy and expanding in-network coverage.”
Dr. Essam Hamza, CEO of Rocket Doctor AI
“As we continue to scale our footprint and strengthen payor relationships, we are laying a strong foundation for sustainable, long-term revenue growth.”
Dr. Essam Hamza, CEO of Rocket Doctor AI
“While U.S. patient volumes grew significantly in Q2, the associated revenue growth was not immediately reflected in our reported results because of the lag between patient visits, claims processing and cash collections.”
Dr. Essam Hamza, CEO of Rocket Doctor AI
“With U.S. patient visits increasing a further 56% in Q3, we expect to begin seeing the financial benefits of that growth as collections catch up with clinical activity.”
Dr. Essam Hamza, CEO of Rocket Doctor AI
“Our expectation of record Q3 revenue is an encouraging indication of that progression.”
Amir Javidan, Chief Executive Officer of WELLSTAR Technologies Corp.
“Completing this transaction is a significant milestone for WELLSTAR, and I want to thank our team for the tremendous work that made it possible.”
Amir Javidan, Chief Executive Officer of WELLSTAR Technologies Corp.
“We are also grateful to our investors for their support of the financing, to our agents and advisors for their guidance throughout the process, to the TSX Venture Exchange for their work on our listing, and to WELL Health for its continued partnership.”
Amir Javidan, Chief Executive Officer of WELLSTAR Technologies Corp.
“We look forward to beginning trading on October 1.”
Richard Staub, President of Research and Development Solutions at IQVIA
“By bringing our companies’ strengths together, we’re giving clinical teams a more connected way to work, built on frictionless integration of our respective technologies.”
Richard Staub, President of Research and Development Solutions at IQVIA
“Just as importantly, customers retain the flexibility to choose the EDC, RTSM, and eCOA technologies and solutions that best meet their needs, including IQVIA’s innovative capabilities.”
NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Artificial intelligence is starting to change the way healthcare works, and the opportunity is getting harder to ignore. From spotting diseases earlier to helping doctors make better decisions, AI is finding its way into more areas of medicine. Hospitals are looking for ways to improve patient care, reduce costs and handle growing workloads, while pharmaceutical companies are turning to AI to speed up drug discovery and research. The money flowing into this market reflects that growing demand. Fortune Business Insights estimates that the global AI healthcare market was worth $39.34 billion in 2025 and could reach $56.01 billion in 2026. Looking further ahead, the firm projects the market could grow to approximately $1.03 trillion by 2034. If adoption continues at that pace, companies developing AI-powered medical tools, diagnostic systems and healthcare software could be competing for a much larger share of the industry. Active Companies in the Healthcare/A.I. industries this week include Tempus (NASDAQ: TEM), Rocket Doctor AI Inc. (OTCQB: AIRDF) (CSE: AIDR), HEALWELL AI Inc. (OTCQX: HWAIF) (TSX: AIDX), IQVIA (NYSE: IQV), WELL Health Technologies Corp. (OTCQX: WHTCF) (TSX: WELL).
Get started
Create a free account to read the full story.